Evidence map›Paper›PMID 39768245›Full record

ReviewLife (Basel, Switzerland)2024

Potential of Stem-Cell-Induced Peripheral Nerve Regeneration: From Animal Models to Clinical Trials.

Taylor M Wynne, Virginia Grey Fritz, Zachary T Simmons, Malek Zahed, Ananya Seth, Tamir Abbasi, Michael J Reymundi, Kelly C S Roballo

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Taylor M WynneDepartment of Biomedical, Edward Via College of Osteopathic Medicine, Blacksburg, VA 24060, USA.
Virginia Grey FritzDepartment of Biomedical, Edward Via College of Osteopathic Medicine, Blacksburg, VA 24060, USA.
Zachary T SimmonsDepartment of Biomedical, Edward Via College of Osteopathic Medicine, Blacksburg, VA 24060, USA.
Malek ZahedDepartment of Biomedical, Edward Via College of Osteopathic Medicine, Blacksburg, VA 24060, USA.
Ananya SethDepartment of Biomedical, Edward Via College of Osteopathic Medicine, Blacksburg, VA 24060, USA.ORCID 0009-0000-4407-7374
Tamir AbbasiDepartment of Biomedical, Edward Via College of Osteopathic Medicine, Blacksburg, VA 24060, USA.
Michael J ReymundiDepartment of Biomedical, Edward Via College of Osteopathic Medicine, Blacksburg, VA 24060, USA.
Kelly C S RoballoDepartment of Biomedical, Edward Via College of Osteopathic Medicine, Blacksburg, VA 24060, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral nerve injury has become an increasingly prevalent clinical concern, causing great morbidity in the community. Although there have been significant advancements in the treatment of peripheral nerve damage in recent years, the issue of long-term nerve regeneration remains. Furthermore, Wallerian degeneration has created an obstacle to long-term nerve regeneration. For this reason, there has been extensive research on the use of exogenous and endogenous stem cells as an adjunct or even primary treatment option for peripheral nerve injury. The plasticity and inducibility of stem cells make them an enticing option for initiating neuronal cell regrowth and optimal sensory and functional nerve regeneration. Peripheral nerve injury has a broad range of causative factors and etiologies. As such, unique stem cell-induced peripheral nerve treatments are being investigated to ameliorate the damage incited by all causes, including trauma, neuropathy, and systemic neurodegenerative diseases. This review is oriented to outline the potential role of stem cell therapies in peripheral nerve injury versus the current standards of care, compare the benefits and drawbacks of specific stem cell lines under investigation, and highlight the current models of stem cell therapy in the peripheral nervous system, with the ultimate goal of narrowing down and optimizing the role and scope of stem cell therapy in peripheral nerve injury.

Indexed as

peripheral nerve injuryperipheral nervous systemregenerationstem celltransplant

Identifiers

PMID39768245
PMCPMC11679741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.